Bcl2 Modifying Factor (BMF) (N-Term) Peptide

Details for Product No. ABIN1382119, Supplier: Log in to see
Protein Name
  • BMF
  • AW260063
  • AW411872
  • Bcl2 modifying factor
  • BCL2 modifying factor
  • BMF
  • bmf
  • LOC100227756
  • Bmf
  • LOC100357766
Protein Region
N-Term
Origin
Human
2
Application
Blocking Peptide (BP)
Options
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Blocked Antibody anti-BMF antibody (Bcl2 Modifying Factor) (N-Term) (ABIN1031277)
Characteristics 13 amino amino terminus of human Bmf.
Human
Research Area Signaling, Cytoskeleton, Apoptosis/Necrosis, Cancer
Application Notes Bmf peptide is used for blocking the. activity of Bmf.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Heiser, Labi, Erlacher, Villunger: "The Bcl-2 protein family and its role in the development of neoplastic disease." in: Experimental gerontology, Vol. 39, Issue 8, pp. 1125-35, 2004 (PubMed).

Tan, Tan, Chan, Yee, Bevort, Ang, Yu: "MAP-1, a novel proapoptotic protein containing a BH3-like motif that associates with Bax through its Bcl-2 homology domains." in: The Journal of biological chemistry, Vol. 276, Issue 4, pp. 2802-7, 2001 (PubMed).

Puthalakath, Villunger, OReilly, Beaumont, Coultas, Cheney, Huang, Strasser: "Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis." in: Science (New York, N.Y.), Vol. 293, Issue 5536, pp. 1829-32, 2001 (PubMed).